Launching an innovative product or technology takes more than a good idea, and there are many actions startups can take to strengthen their offering and overall chance of success as they develop the latest innovations to bolster health security, including battling COVID-19. Over the last year, the global scientific community has proven critical to our collective ability to combat the pandemic, andBLUE KNIGHT™offers a new way to build the kinds of partnerships needed to advance potentially life-saving technology during public health emergencies.
蓝色的骑士是Johnson＆Johnson Innovation（JLABS）与生物医学高级研发局（Barda）之间的共同举措，旨在通过为战略性地调整的初创公司提供支持并通过提升重要主题，并通过支持更加准备和受保护的未来的道路专家编程。
Investing in Your Success: Tips for a Strong Pitch
At the close of 2020, we joined the culminating session of the蓝色的骑士Symposium讨论投资和培养早期创新以提高健康安全的策略。在研讨会上，我们亲眼目睹了当全球专家聚集在一起时，我们能够更深入地调查以应对挑战并确定优先事项以加强准备和健康安全。
We were joined by internationally recognized innovation leader, Geoffrey Ling, M.D., Ph.D., for a forthright dialogue that provided early-stage innovators with tips for overcoming barriers. The panel was led by entrepreneur Stephanie Culler, Ph.D., Co-Founder and CEO of Persephone Biosciences, a蓝色的骑士company. Here are key takeaways from the discussion.
To fuel early-stage, high-risk innovations, we look for ideas with the potential to cross the ultimate finish line: meeting the unmet needs of patients. By offering transparent advice, we hope to help those on the frontlines of innovation develop stronger proposals, foster connections, and access the support needed to make their next big move.
- Establish your vision.Having a cutting-edge idea and deep understanding of its scientific basis is key, but it can be even more critical to clearly articulate the transformational impact this science could have on public health. We see a lot of solutions that are lacking a compelling problem. A flashy technology is not attractive if there is no potential application – to have a disruptive idea, you need to be solving an existing or anticipated challenge.您的解决方案解决了什么问题？您的创新是否有可能提高诊断的获取和效率？它是一种具有成本效益的解决方案，可以帮助解决医疗保健方面的差异吗？Not all innovative technologies need to be transformational or revolutionary, but they do need to be impactful in addressing a public health need. You must be visionary in the early stages of your company by considering the potential value your innovation brings to the market and articulating that upfront in your pitch.
- Diversify your customers.Whenconsidering markets for science and technology aiming to address global health threats, identifying a ”dual utility” or多用途值application is a sustainable and adept approach. Dual utility or multi-use products and technologies are developed to have both commercial and biodefense applications, thus enhancing our ability to respond effectively to a broad array of threats and in emergency situations. Public and private partners are eager to engage with promising ideas that have dual-use potential, because – as Dr. Ling of On Demand Pharmaceuticals explained during the panel – “Dual use products are important from many aspects…selling to the government is a limited market; you have to expand your product’s market potential, so finding an application that the civilian sector would also embrace gives you access to much more capital… and therefore the ability to make further improvements and investments in your product.”
- Diversify your partners. A multi-use model also opens the door to a more diverse group of prospective partners, thus expanding the advice and mentorship you may have access to. Potential partners are always looking to mitigate risk when supporting novel ideas, and multi-use applications create a chance to strategically align and share risk across multiple invested stakeholders. By bringing together different stakeholders, all parties involved will expand their knowledge networks.
- Strengthen your team.对于潜在的投资者，一支杰出的团队可能与引人注目的想法一样重要。评估提案时，我们不仅在研究您的科学，而且还要关注您的管理团队，创始人和外部支持网络。一个破坏性的想法通常来自一个强大的科学团队，但是缺乏策略和管理方面的知识可能是致命的缺陷。通过企业家面临的业务，合法和监管障碍，以使他们的产品触及患者和消费者的智慧。重要的是要积极地建立牢固和多样化的关系 - 尤其是在具有丰富经验的创新经验并提供广泛背景和观点的导师中。资深的创新者可以帮助消除猜测，并帮助初创企业在推进他们的想法时保持前瞻性。
- Diversify your funding.同样重要的是保持开放的各种类型s of funding. There can be a tension around the balance of dilutive and non-dilutive funding. Non-dilutive funding is often extremely attractive to a startup because itwon’treduce shareholder value for founders and existing investors – and it can potentially lead to more rapid validation. Though, the amount of time it takes to secure non-dilutive funding and the constraints and reporting required are downsides to consider. From a venture perspective, you should always look more holistically at business models and funding options before identifying the best path forward.
If you are interested in taking a deeper dive into any or all of these concepts, check out the full remarks in ouron-demand presentation.
Connecting to Catalyze: An Opportunity to Access an Expert Network
归根结底，即使有了正确的科学，正确的目标市场以及正确的资金，将想法带入市场的途径也容易发生绕道和障碍。成功需要创造力和坚定的激情。我们认为，建立一个多元化利益相关者网络的企业家 - 所有人都对他们的成功充满热情，并将在那里帮助居住和坚持不懈 - 可能有更大的机会向患者提供解决方案。
By finding partners and mentors in the early stages, entrepreneurs can gain the expertise and insights to look ahead to anticipate and mitigate risks.
如果您正在研究创新的前线，目的是提高健康安全性，我们希望收到您的来信。我们的蓝色的骑士合作的成立是对当今有申请的创新的浓厚兴趣，同时提高了我们准备应对明天未知威胁的准备。曼联，我们能够通过Johnson＆Johnson Companies和Barda Networks的强大，多专业的指导和资源提供有希望的初创公司。乐动体育意甲直播
现在开始建立联系并建立基础和支持，这可能有助于推动您的科学或技术前进为止。如果您准备提高令人信服的想法，以改善对健康威胁的准备和反应，请访问蓝色的骑士websiteto get connected or apply to join.
About the Authors
- Christopher Houchens博士，美国卫生与公共服务部生物医学高级研发局（BARDA）的CBRN医学对策司司
- Marian Nakada, Ph.D., Vice President, Venture Investments, Johnson & Johnson Innovation – JJDC, Inc.
####
免责声明：
本博客中涵盖的内容仅用于教育和信息目的，可能包含与Johnson＆Johnson Innovation LLC的人和组织的意见，和/或其父母或附属公司（以下简称以下称为“ JJI”）。ld乐动JJI对内容，观点，建议或所介绍的信息不做任何陈述，明示或暗示。此内容并非旨在影响JJI，Johnson＆Johnson或其分支机构的任何产品或服务的使用，销售，建议或推广。